The Hospice Patient on 10+ Medications: A Signal, Not a Standard

As clinical goals shift toward comfort and symptom burden becomes the primary driver of decision-making, medication regimens often persist without a corresponding shift in therapeutic intent. Medication count is a prompt to review that intent, not a performance metric.

Why does polypharmacy persist in hospice?

 
Three overlapping factors usually drive persistent polypharmacy in hospice: 

When should a medication list trigger a structured reassessment?

A list of 10 or more scheduled medications should not, on its own, be treated as a threshold of concern. It is a practical signal to perform a structured review when clinical context changes,  particularly in these situations:

• Admission to hospice or transition from hospital or rehab
• Significant decline in functional status, such as a drop in PPS or increased dependency
• Re-certification periods or a documented change in trajectory 
• New swallowing difficulty, reduced oral intake, or escalating caregiver burden
• Emergence of delirium, hypotension, falls, sedation, or unexplained decline
• Ongoing use of medications intended for long-term prevention rather than symptom control

These triggers are most clinically meaningful when they prompt reassessment of therapeutic intent — not just automatic continuation.

What four questions guide hospice deprescribing?

For each scheduled medication, a structured clinical reassessment can be guided by four questions:

This framework shifts decision-making away from disease-based continuation and toward time-sensitive therapeutic relevance.

Which medication classes commonly persist beyond their usefulness?

Certain categories frequently persist beyond their clinical utility in hospice because their original benefit is delayed, preventive, or no longer aligned with goals of care:

Across these categories, the clinical issue is rarely appropriateness at initiation — it is the absence of structured discontinuation once the therapeutic context changes.

Is deprescribing the same as removing medications?

Deprescribing in hospice is often misunderstood as simply "removing" medications.  In practice, it is better understood as a reassessment of therapeutic intent in the setting of limited prognosis. This process weighs:

• The patient's current symptom burden and trajectory
• Likelihood and timing of benefit relative to prognosis
• Immediate and cumulative adverse-effect risk
• Administration complexity and caregiver capacity
• Alignment with comfort-focused goals of care

Within this framework, medication count is not a performance metric. It is a signal that the original therapeutic intent of multiple agents may not have been formally re-evaluated in light of changing clinical context.